Health Canada has updated the Cosmetic Ingredient Hotlist, adding two new substances:
1. Ethylhexyl Ethylhexanoate
• A maximum concentration of:
o 0.1% for body lotion
o 0.5% for foot lotion
o 0.6% for face make-up
2. Azelaic acid and its salts
• With a maximum permitted concentration of 14%
Additionally, the following amendments were made to the Hotlist:
• Retinoic acid and its salts
o Prohibited ingredient for use in cosmetic products
o “This entry was amended to add salts for clarity. Salts are expected to convert to retinoic acid when mixed in solution. Retinoic acid has known therapeutic action at low concentration, with marketed prescription drugs for topical use containing retinoic acid at a concentration as low as 0.01% listed in Health Canada’s Drug Product Database.”
• Eucalyptus oil
o Products not in solid form with greater than 0.022% eucalyptus oil shall have the cautionary statement, “Keep out of reach of children", and "In case of accidental ingestion, call a Poison Control Centre or doctor immediately and advise them this product contains eucalyptus oil."
o “The entry was amended to better mitigate the risk of unintentional ingestion, particularly in pediatric populations, by introducing cautionary label statements for certain products with concentrations greater than 0.022%.”
• Peroxide and peroxide-generating compounds
o “The entry was amended to clarify that for oral cosmetics containing more than 3% hydrogen peroxide (or equivalent) hydrogen peroxide concentrations in saliva will continue to be requested but, concentrations within the soft tissue of the oral cavity will not be routinely requested. Furthermore, the statement allowing evidence that may include analog studies from recognized sources or independent clinical research was removed.”
• p-Hydroxyanisole
o “The entry was amended to expand the permitted nail product categories to include products for consumer use, and increase the maximum concentration permitted for these products.”
It should be noted that the updates to Alpha-hydroxy acids and Retinoic acid derivatives have been postponed for further review.
Link: https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients/changes.html#aug2022
How Does this Impact You? Contact Us to Discuss
If you have any questions, please contact your customer service representative or email: info@us.bureauveritas.com
22b-077
Download Regulatory Update
DOWNLOAD